openPR Logo
Press release

Bacterial Conjunctivitis Drugs Market: Rising Prevalence of MDROs Creates Serious Challenge for Market’s Growth

02-24-2017 03:02 PM CET | Health & Medicine

Press release from: TMR

Bacterial Conjunctivitis Drugs Market: Rising Prevalence

Bacterial conjunctivitis is a commonly encountered eye problem across the world, caused by various bacterial strains such as streptococci, staphylococci, chlamydial, and gonococci organisms. Majority of the cases of bacterial conjunctivitis are self-limited and acute and not a major cause of morbidity. This study provides market analysis for various antibacterial drug classes used for the treatment of bacterial conjunctivitis. The stakeholders of this study comprise established pharmaceutical companies involved in the commercialization of antibacterial drugs as well as new participants who wish to enter the U.S. market.

View Exclusive Global Strategic Business Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12323

This market study provides a complete analysis of the bacterial conjunctivitis drugs market in the U.S. and helps in identifying various market governing factors. The market overview section provides exhaustive information of the incidence rate of bacterial conjunctivitis, list of API manufacturers, patent challenges, market trends such as drivers, restraints, and growth opportunities that currently control the dynamics of the overall market. The section also recommends and predicts the future conditions of the market.

Market strategy tools such as event impact assessment and Porter’s Five Forces analysis have also been incorporated in this report to provide balanced analysis about the level of competition within the bacterial conjunctivitis drugs market in the U.S. Executive summary provided in the report encapsulates comprehensive insights about every segment considered in this study. Besides, it includes a market snapshot, which offers a glimpse into the current scenario of the bacterial conjunctivitis drugs market in the U.S. in terms of current and future market size along cumulative growth rate.

Additionally, this study includes a regulatory framework segment wherein the overall regulatory scenario of the U.S. drugs policy has been described. Participant analysis tools such as market share analysis have also been included in the market overview section of the report to deliver a broad spectrum of the overall market scenario in the bacterial conjunctivitis drugs market in the U.S.

The bacterial conjunctivitis drugs market in the U.S. has been segmented based on various antibacterial drug classes. The market is segmented into major types of antibacterial drugs such as fluoroquinolones, aminoglycosides, macrolides, and others. The fluoroquinolones segment has been sub-segmented into ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin, gatifloxacin, and besifloxacin. Aminoglycosides has been sub-segmented into tobramycin and gentamycin.

Macrolides has been divided into erythromycin and azithromycin. The others segment is analyzed cumulatively, considering bacitracin, fusidic acid and ceftriaxone within this class. The market size for the period from 2012 to 2024 has been provided for each of the major drug classes mentioned above in terms of USD million. Along with the market size that were projected considering 2013 as the base year and 2012 as the historical year, the CAGR (%) of each market segment for the forecast period from 2012 to 2018 and 2018 to 2024 have also been provided.

The report concludes with detailed profiles of leading players in the bacterial conjunctivitis drugs (antibacterials) market in the U.S. The study profiles the companies in terms of overview, financial overview, product portfolio, business strategies, and recent developments. Major organizations profiled in this report include Actavis plc, Akorn, Inc., Bayer AG, F. Hoffmann-La Roche, Ltd., Merck & Co., Inc., Novartis AG, Perrigo Company plc, Pfizer, Inc., Santen Pharmaceutical Co., Ltd., and Valeant Pharmaceuticals International, Inc.

Browse Research Report: http://www.transparencymarketresearch.com/us-bacterial-conjunctivitis-drugs-market.html

Additionally, market share analysis that has been provided in context with the major pharmaceuticals operating in the market would help new participants to understand the key business perceptions and frameworks and to identify the specific product lines of the existing companies to establish a strong foothold in the bacterial conjunctivitis drugs market in the U.S.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bacterial Conjunctivitis Drugs Market: Rising Prevalence of MDROs Creates Serious Challenge for Market’s Growth here

News-ID: 448857 • Views: 438

More Releases from TMR

Email Security Market Provides Detailed Insight by Trends, Challenges, Opportuni …
Email Security - Introduction Email security is a secure email communication technique to transfer and access sensitive information against unauthorized loss and compromise. Increase in digitization and adoption of cloud email services in different industries to reorganize the email security architecture of companies is expected to fuel the adoption of email security solutions in companies. Adoption of email security solutions in enterprises eliminates the need for expensive security solutions providers, which further improves
Federated Learning Solutions Market Projections, COVID-19 Pandemic Shaping Globa …
Federated Learning Solutions: Introduction Implementation and adoption of artificial intelligence and machine learning technology in all verticals changes the overall shape of the market. Federated learning solutions is a new machine learning technique which can be used to train an artificial intelligence model. Federated learning solutions are used to solve the problem of building a machine learning model that utilizes datasets distributed cross-platform. Some of the key sectors which are adopting federated learning
IoT in Construction Market Projected to Gain Significant Value through 2022-2031
The global IoT in construction market was valued over US$ 7.6 Bn in 2021. It is estimated to expand at a CAGR of 16.2% from 2022 to 2031. The global IoT in construction market is expected to reach value of US$ 34 Bn by the end of 2031. Analysts' Viewpoint on Global IoT in Construction Market Global IoT in Construction Market Introduction Internet of Things (IoT) is important for digitalization in the construction
Cloud Kitchen Market Present Scenario and Growth Prospects, 2021-2031
The expanding dining and food delivery industry coupled with an increase in the disposable income of many individuals around the globe will prove to be growth boosters for the cloud kitchen market during the forecast period of 2021-2031. The preference for online food services has increased exponentially over the years. This factor will also serve as a growth accelerator for the cloud kitchen market. Want to know the obstructions to your

All 5 Releases


More Releases for Bacterial

Anti-Bacterial Hand Sanitizer Market 2020
This report also analyses the impact of Coronavirus COVID-19 on the Anti-Bacterial Hand Sanitizer industry. Based on our recent survey, we have several different scenarios about the Anti-Bacterial Hand Sanitizer YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Anti-Bacterial Hand Sanitizer will reach xx
Global Bacterial and Viral Specimen Collection Market
According to a new market research report published by Global Market Estimates, the Global Bacterial And Viral Specimen Collection Market is expected to grow at a CAGR of 14.05%. The demand for Bacterial and Viral Specimen Collection is projected due to the increasing preference for effective residential kitchen tools. Browse 142 Market Data Tables and 108 Figures spread through 165 Pages and in-depth TOC on "Bacterial and Viral Specimen Collection Market
Acute Conjunctivitis Treatment Market | Bacterial conjunctivitis | PBIGP
The Future Insights Of Global Acute Conjunctivitis Treatment Market Conjunctivitis, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Conjunctivitis can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but treatment can
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as
Bacterial Gastroenteritis Testing Market Future Opportunities 2026
Bacterial gastroenteritis is infection in the gut (gastrointestinal tract). Major bacteria causing gastroenteritis are C. difficile, C. jejuni, shigella, E. coli, and several species of salmonella. These bacteria are usually transmitted by means of ingesting contaminated food or liquids, person-to-person contact, and contact with animals. The diseases caused by these bacteria may be asymptomatic or may have mild to severe symptoms. Some of the common symptoms caused by enteric bacteria
Bacterial Vaginosis Drug Market is Growing Rapidly Due To Rising Awareness About …
Worldwide Market Reports added Latest Research Report titled "Global Bacterial Vaginosis Drug Market by Manufacturers, Regions, Product Type and Application, Forecast to 2022" to its Large Report database. In this report, the global Bacterial Vaginosis Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Ask For Sample Copy